Le Dog, A Breakthrough Product for Pets

Le Dog®

a Breakthrough Product for Pets (2 new Drug Patents)


From the Inventor of Advanced Neosporin, Advanced Lubriderm, EPT, and discovery of the use of Rx Rezulin for Type II Diabetes earlier in his career at Warner Lambert (acquired by Pfizer), EmphyCorp Patented Rx Nasal Sprays with no known side effects treatments for Respiratory, Long COVID, Flu, and Racehorses (increasing oxygen levels/helps prevent bleeding in the nasal cavity), comes the new Le Dog Product with 2 new Drug Patents, the first of its kind, medicinal Anti-Anxiety Drug for Pets.

Fear and anxiety in dogs are common causes of a variety of behavioral disorders that affect the lives of dogs or pets, as well as for those who live and work with them. 

The Le Dog product represents the first time that a clinically proven medicinal blend of safe, specific patented natural ingredients in combination with essential oils will be applied directly into the    nasal cavity of the animal via delivery systems including aerosol and/or nasal spray.

In our studies of dogs, those selected for the studies exhibited anxiety when their owners left home for work. They exhibited a variety of anxiety disorders including aggression, urinating, or defecting in the home, drooling, panting, destructive behavior, depression, excessive barking, and pacing.

How it works: 

The enhancement and increase of the synthesis of brain Serotonin levels in the Pet reduces anxiety.

The down-regulating of in-vivo levels of inflammatory cytokines in the nasal cavities of Pets. Additionally, through the addition of antioxidants, the formula serves to reduce the inflammation within the animal’s nasal cavity, thereby allowing the product and essential oils to work more effectively.

In addition to household Pets such as Cats and Dogs (both feral and non-feral), Le Dog could also be used to reduce anxiety in non-human mammals such as farm animals, racehorses, including both temporarily captured or wild animals.

Le Dog product image